The burden of infectious diseases falls disproportionally on the world’s poorest countries. The Doherty Institute conducts research in low and middle-income countries, with a particular focus on our regional neighbours, the purpose of which is to improve health outcomes for patients and communities.
The Doherty Institute has a high level of expertise in global health. Home to the World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, the WHO Collaborating for Antimicrobial Resistance and the WHO Collaborating Centre for Viral Hepatitis, these Centres provide extensive training and technical advice to health practitioners and governments in the Asia-Pacific region. Additionally, the Institute is home to WHO Regional Reference Laboratories for vaccine-preventable invasive bacterial diseases, measles and rubella, poliovirus, and hepatitis B. These Reference Laboratories provide expert laboratory services, training and technical support to colleagues in regional countries.
The Doherty Institute is home to internationally recognised research leaders addressing the challenges of dengue, malaria, typhoid, HIV, tuberculosis, antimicrobial resistance, maternal and child health, and early-life nutrition. In many cases, these research efforts have their centre of gravity in low and middle-income countries in our region, where the outcomes of the research can have the greatest benefit. The Doherty Institute’s robust network of regional linkages and collaborations enables a rapid public health and research response to new emerging infectious disease threats in the region.